News
MicroPort® Appoints Greg Holman as Chief Commercial Officer
27 May 2026
® Appoints Greg Holman as Chief Commercial Officer
Earlier from Microport Scientific
- MicroPort Scientific: APOLLO Dream® Sirolimus Target Eluting Stent System Granted FDA Breakthrough Device Designation
- MicroPort Scientific: FDA Grants Breakthrough Device Designation to Endovastec™’s Hector™ Multi-Branch Thoracic Stent Graft System
- MicroPort Scientific: Toumai® Laparoscopic Surgical Robot Surpasses 200 Global Commercial Orders
- MicroPort Scientific: CardioFlow Announces Commercial Launch of FLEXIGO™ 3D delivery system for LBBAP in Europe and Australia